AAIC 2018: Treating non-cognitive symptoms of individuals with dementia
New research, presented at the Alzheimer’s Association International Conference (21–26 July, IL, USA), focuses on the treatment of non-cognitive symptoms of individuals with Alzheimer’s disease (AD). Behavioral and psychological symptoms of dementia include: agitation, anxiety, apathy, depression, wandering, hallucinations, insomnia, incontinence and disinhibition, and these often cause the greatest challenges to caregivers and reduction in quality of life. There are currently no US FDA-approved drug treatments for these symptoms associated with AD, and any treatments currently utilized to control the non-cognitive symptoms are approved for other indications and prescribed ‘off-label’. “These under-recognized and undertreated symptoms in people with Alzheimer’s and...